soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Scorecard: soul trial oral semaglutide cardiovascular

Elevated Heart Rate: L-carnitine may increase heart rate and blood pressure in some individuals, posing risks for those with existing cardiovascular conditions

Converts white adipose tissue into brown adipose tissue (a phenomenon called fat tissue browning) to prevent body disfigurement associated with obesity and overweight

For instance, a study in Lancet reported that individuals taking semaglutide achieved substantial weight loss compared to those not using the medication

The documented schedule holds each step for about four weeks specifically because faster escalation sharply increases nausea and vomiting and drives dropout

Weight-related conditions include high blood pressure, type 2 diabetes and high cholesterol